Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
391 News Items found
An illustration of lung develop alongside tumor evolution
In the Lab
By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
The human papillomavirus (HPV)
Finding
According to Memorial Sloan Kettering scientists, it has to do with what the virus does to a cell’s DNA repair machinery.
Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.
Feature
The drug targets a protein called HER2 found on some salivary gland tumors.
An illustration of a magnifying glass over a brain.
Finding
A targeted approach being developed to treat certain cancers may also be effective for Alzheimer’s disease.
Cancer biologist Scott Lowe at a white board
Feature
This research marks the first time researchers have found a connection between vitamin B6 and cancer.
Graphical representation of cells leaking into bloodstream
In the Lab
Scientists are learning that — in a literal sense — metastasis is wound healing gone wrong.
Epithelial cells
In the Lab
New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition.
Physician-scientist Piro Lito
In the Lab
Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.
a design of colored lines and dots
In the News
As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.